Hone Health vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

MEDVi beats Hone Health overall, scoring 7.7/10 vs 7.3/10. MEDVi is more affordable at $299/mo vs $309/mo. Choose Hone Health for users who want a full-service health platform covering weigh. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of Hone Health and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Hone Health

#39 of 48
7.3/10

Comprehensive men's health platform that includes GLP-1 medications alongside hormone optimization and lab testing.

Visit Hone Health
Higher Rated

MEDVi

#22 of 48
7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi
FeatureHone HealthMEDVi
Our Score7.3/107.7/10
Starting Price$309/mo$299/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoNo
Best ForUsers who want a full-service health platform covering weight loss plus hormones and labsUsers who want a low entry price with oral and injectable compounded options
Ranking#39#22

Pros & Cons Compared

Hone Health

Pros

  • +40+ biomarker lab panel included — the most comprehensive baseline testing of any GLP-1 telehealth provider
  • +Full health optimization platform covering hormones, longevity, and metabolic health beyond just weight loss
  • +Starts patients on gentler liraglutide before escalating — reduces first-week side effect severity
  • +Both compounded and potentially brand-name GLP-1 options available depending on clinical assessment

Cons

  • Layered pricing: $65 initial consult + $149/mo membership + medication cost = $300-650/mo total — one of the most expensive options
  • Select state availability — not available nationwide, and coverage varies by specific treatment program
  • The $149/mo membership fee is required even before you can purchase any medication

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
  • +Sleek onboarding experience with clear progress tracking through their patient portal
  • +$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

  • Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
  • No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out Hone Health with a score of 7.7/10 vs 7.3/10. If budget is your priority, MEDVi starts at $299/mo compared to Hone Health's $309/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose Hone Health if you want: users who want a full-service health platform covering weight loss plus hormones and labs. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Hone Health nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Hone Health

Starting at $309/mo

Visit Hone Health

Try MEDVi

Starting at $299/mo

Visit MEDVi

Related comparisons

Other matchups readers comparing Hone Health or MEDVi tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.